[{"Assets_0_Q3_USD":"734976000.0","CIK":"1628171","CommonStockSharesIssued_0_Q3_shares":"73654880.0","CommonStockSharesOutstanding_0_Q3_shares":"73654880.0","Country":"United States","Industry":"Specialty Chemicals","Market":"NASDAQ","Market Cap":"1775342076.0","NetCashProvidedByUsedInOperatingActivitiesConverted_3_Q3_USD":"-107915000.0","NetIncomeLossAvailableToCommonStockholdersBasic_1_Q3_USD":"-52940000.0","NetIncomeLossAvailableToCommonStockholdersBasic_3_Q3_USD":"-134415000.0","NetIncomeLoss_1_Q3_USD":"-52940000.0","NetIncomeLoss_3_Q3_USD":"-134415000.0","OfficialName":"Revolution Medicines Inc. Common Stock","ProfitLoss_3_Q3_USD":"-134415000.0","RevenuesConverted_1_Q3_USD":"1101000.0","RevenuesConverted_3_Q3_USD":"19930000.0","SP500":null,"Sector":"Consumer Durables","StockholdersEquity_0_Q3_USD":"638204000.0","Ticker":"RVMD","WeightedAverageNumberOfShareOutstandingBasicAndDiluted_1_Q3_shares":"73535686.0","WeightedAverageNumberOfShareOutstandingBasicAndDiluted_3_Q3_shares":"72467677.0","filed":"20211110","footnote":null,"form":"10-Q","fp":"Q3","fy":"2021.0","name":"REVOLUTION MEDICINES, INC.","period":"20210930","qtrs":"0","uom":"USD"}]